Business
GreenGro Technologies, Inc. Announces Shift in Business Strategy as it Launches Into Cannabis Breeding and Cloning Industry
GreenGro Technologies, Inc. Announces Shift in Business Strategy as it Launches Into Cannabis Breeding and Cloning Industry.
About this update from Greengro Technologies, Inc.
[{"type":"text","content":"\n\n ANAHEIM, Calif., Sept. 13, 2017 (GLOBE NEWSWIRE) -- GreenGro Technologies, Inc. (OTC:GRNH), a world-class provider of eco-friendly green technologies, today announced today a strategic shift in its business strategy as it enters into the cannabis breeding and cloning industry.  This move is reflected by today’s announcement that GreenGro Technologies has entered into an agreement with KGBI Colorado, a leading retailer and cultivator of medical marijuana, to build and operate a state-of-the-art medical marijuana breeding and cloning laboratory to be in Denver, Colorado. \n GreenGro’ s Potential Success in Cannabis Breeding and Cloning Business to be Secured by Proprietary Technology and World-Leading Geneticists The facility’s competitive advantages will include, full automation, temperature control and, most importantly, the implementation of GreenGro’ s proprietary greenhouse technologies, which should enable GreenGro Technologies to rapidly capture market share of what could be the cannabis industry’s most lucrative and fastest growing sector: the breeding and cloning of medical marijuana.  In an effort to even further solidify GreenGro’ s position in this growth sector, the Company’s breeding and cloning business will be launched and expanded by Dr. Maqsood Rehman, who has over 12 years of extensive plant breeding and genetics experience in his prior roles. Under the terms of this initial agreement, Geno breeding, a subsidiary of GreenGro Technologies, has partnered with KGBI Colorado to discover and introduce a variety of the most sought-after cannabis strains through modern breeding technologies. This agreement includes the use of conventional and modern breeding techniques to develop high quality cannabis strains for medical use. A group of geneticists, with specialized scientific backgrounds in plant breeding, led by Dr. Rehman will focus on developing cannabis strains that have the optimal levels of THC, CBD, and terpenes.  GreenGro to Embark on New Era of Growth, Expansion and Profitability “Our entry into the business of cloning and breeding of cannabis is a historic day for our company,” said James Haas, Chairman and CEO of GreenGro Technologies, Inc.  “Everyone in our organization has played a critical role in this journey to wh...